Skip to content
evidenceevidencedemonstrativeFederal Criminal TrialDefense Exhibit 10685Contains calculations from customer-receipt and option or stock-proceeds rows in Exhibit 5172. It was also described in closing argument as a Theranos record reflecting more than $200 million in deferred revenue.
← All Evidence
Demonstratives

Defense Exhibit 10685

Contains calculations from customer-receipt and option or stock-proceeds rows in Exhibit 5172. It was also described in closing argument as a Theranos record reflecting more than $200 million in deferred revenue.

3 proceedings3 mentions1 trial
Also known as (3)
  • Exhibit 10685
  • Option/stock proceeds summary
  • Theranos record reflecting more than $200 million in deferred revenue

Trial Record (3)